Medicinova (MNOV)

Medicinova (MNOV) Stock Price & Analysis


MNOV Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.89 - $2.77
Previous Close$2.15
Average Volume (3M)19.83K
Market Cap
Enterprise Value$49.85M
Total Cash (Recent Filing)$55.26M
Total Debt (Recent Filing)$142.20K
Price to Earnings (P/E)-7.8
Apr 26, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.28
Shares Outstanding49,049,246
10 Day Avg. Volume12,333
30 Day Avg. Volume19,827
Standard Deviation0.14
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-3.36
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Medicinova’s price range in the past 12 months?
Medicinova lowest stock price was $1.89 and its highest was $2.77 in the past 12 months.
    What is Medicinova’s market cap?
    Currently, no data Available
    When is Medicinova’s upcoming earnings report date?
    Medicinova’s upcoming earnings report date is Apr 26, 2023 which is 36 days ago.
      How were Medicinova’s earnings last quarter?
      Medicinova released its earnings results on Jul 27, 2022. The company reported -$0.15 earnings per share for the quarter, missing the consensus estimate of -$0.087 by -$0.063.
        Is Medicinova overvalued?
        According to Wall Street analysts Medicinova’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Medicinova pay dividends?
          Medicinova does not currently pay dividends.
          What is Medicinova’s EPS estimate?
          Medicinova’s EPS estimate is -$0.07.
            How many shares outstanding does Medicinova have?
            Medicinova has 49,049,248 shares outstanding.
              What happened to Medicinova’s price movement after its last earnings report?
              Medicinova reported an EPS of -$0.15 in its last earnings report, missing expectations of -$0.087. Following the earnings report the stock price went down -1.835%.
                Which hedge fund is a major shareholder of Medicinova?
                Among the largest hedge funds holding Medicinova’s share is Caxton Associates LP. It holds Medicinova’s shares valued at N/A.


                  Medicinova Stock Smart Score

                  The Medicinova stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description


                  MediciNova, Inc. is a biopharmaceutical company, which engages in the acquisition and development of small molecule therapeutics for the treatment of serious diseases for the treatment of diseases with unmet medical need. Its development pipeline consists of clinical-stage compounds for the treatment of acute exacerbations of asthma and COPD, progressive multiple sclerosis, methamphetamine addiction, neuropathic pain, asthma, interstitial cystitis, and solid tumor cancers. The company was founded by Yuichi Iwaki on September 26, 2000 and is headquartered in La Jolla, CA.


                  Top 5 ETFs holding MNOV

                  Market Value
                  Smart Score
                  iShares Core S&P Total U.S. Stock Market ETF
                  Up to five ETFs with an Outperform Smart Score that hold MNOV. The ETFs are listed according to market value of MNOV within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Ovid Therapeutics
                  X4 Pharmaceuticals
                  KalVista Pharmaceuticals

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis